Dec 22 (Reuters) - Nuvo Research Inc NRI.TO :
* Research reacquires pliaglis North American development and marketing rights
* Has reacquired pliaglis development and marketing rights for the U.S., Canada
and Mexico
* Says has reacquired pliaglis development and marketing rights for the U.S.,
Canada and Mexico
* Under terms of the agreement, Nuvo paid galderma 125,000 Swiss francs
* Under terms of the agreement, Nuvo will pay an additional 125,000 Swiss
francs upon transfer of certain rights and documents
* Beginning in 2021, Nuvo has the right to reacquire the rest of world rights
on a country-by-country basis
* Source text for Eikon
* Further company coverage NRI.TO